Identification Generic Name (1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate DrugBank Accession Number DB08497 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate (DB08497) ×  Close Weight Average: 366.3243  Monoisotopic: 366.08518619  Chemical Formula C 19 H 14 N 2 O 6 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Caspase-3 Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as 1,4-isoquinolinediones. These are isoquinoline derivatives carrying a C=O group at positions 1 and 4, respectively. Kingdom Organic compounds Super Class Organoheterocyclic compounds Class Isoquinolines and derivatives Sub Class 1,4-isoquinolinediones Direct Parent 1,4-isoquinolinediones Alternative Parents 1,3-isoquinolinediones  /  Isoquinolones and derivatives  /  Tetrahydroisoquinolines  /  Phenylacetamides  /  Benzyloxycarbonyls  /  Aryl ketones  /  N-arylamides  /  Vinylogous amides  /  N-unsubstituted carboxylic acid imides  /  Dicarboximides  /  Secondary carboxylic acid amides  /  Carboxylic acid esters  /  Azacyclic compounds  /  Monocarboxylic acids and derivatives  /  Organopnictogen compounds  /  Organic oxides  /  Hydrocarbon derivatives 
 
 
  show 7 more Substituents 1,3-isoquinolinedione  /  2,3-dihydroisoquinoline-1,4-dione  /  Aromatic heteropolycyclic compound  /  Aryl ketone  /  Azacycle  /  Benzenoid  /  Benzyloxycarbonyl  /  Carbonyl group  /  Carboxamide group  /  Carboxylic acid derivative  /  Carboxylic acid ester  /  Carboxylic acid imide  /  Carboxylic acid imide, n-unsubstituted  /  Dicarboximide  /  Hydrocarbon derivative  /  Isoquinolone  /  Ketone  /  Monocarboxylic acid or derivatives  /  Monocyclic benzene moiety  /  N-arylamide  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Phenylacetamide  /  Secondary carboxylic acid amide  /  Tetrahydroisoquinoline  /  Vinylogous amide 
 
 
  show 20 more Molecular Framework Aromatic heteropolycyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key NKBDSMREMMRFSI-INIZCTEOSA-N InChI InChI=1S/C19H14N2O6/c1-10(22)27-16(11-6-3-2-4-7-11)19(26)20-13-9-5-8-12-14(13)15(23)18(25)21-17(12)24/h2-9,16H,1H3,(H,20,26)(H,21,24,25)/t16-/m0/s1 IUPAC Name (S)-phenyl[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)carbamoyl]methyl acetate SMILES [H][C@@](OC(C)=O)(C(=O)NC1=CC=CC2=C1C(=O)C(=O)NC2=O)C1=CC=CC=C1 References General References Not Available External Links PubChem Compound 24883486 PubChem Substance 99444968 ChemSpider 25058806 ZINC ZINC000013683220 PDBe Ligand RXB PDB Entries 3dei Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.0126 mg/mL ALOGPS logP 1.91 ALOGPS logP 2 Chemaxon logS -4.5 ALOGPS pKa (Strongest Acidic) 5.51 Chemaxon pKa (Strongest Basic) -7 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 5 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 118.64 Å 2 Chemaxon Rotatable Bond Count 5 Chemaxon Refractivity 94.33 m 3 ·mol -1 Chemaxon Polarizability 34.93 Å 3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.8981 Blood Brain Barrier + 0.6862 Caco-2 permeable - 0.5616 P-glycoprotein substrate Non-substrate 0.5461 P-glycoprotein inhibitor I Inhibitor 0.5079 P-glycoprotein inhibitor II Non-inhibitor 0.5154 Renal organic cation transporter Non-inhibitor 0.9448 CYP450 2C9 substrate Non-substrate 0.7817 CYP450 2D6 substrate Non-substrate 0.8666 CYP450 3A4 substrate Non-substrate 0.5528 CYP450 1A2 substrate Inhibitor 0.5841 CYP450 2C9 inhibitor Non-inhibitor 0.6309 CYP450 2D6 inhibitor Non-inhibitor 0.9447 CYP450 2C19 inhibitor Non-inhibitor 0.7158 CYP450 3A4 inhibitor Non-inhibitor 0.8107 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.5 Ames test Non AMES toxic 0.7246 Carcinogenicity Non-carcinogens 0.9046 Biodegradation Not ready biodegradable 0.9138 Rat acute toxicity 2.0537 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9938 hERG inhibition (predictor II) Non-inhibitor 0.863    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Caspase-3 Kind Protein Organism Humans Pharmacological action Unknown General Function Phospholipase a2 activator activity Specific Function Involved in the activation cascade of caspases responsible for apoptosis execution. At the onset of apoptosis it proteolytically cleaves poly(ADP-ribose) polymerase (PARP) at a '216-Asp-|-Gly-217' ... Gene Name CASP3 Uniprot ID P42574 Uniprot Name Caspase-3 Molecular Weight 31607.58 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:32 / Updated at June 12, 2020 16:52 